Biochemical characterization of a protein tyrosine phosphatase from Trypanosoma cruzi involved in metacyclogenesis and cell invasion

• Autor(a) principal: Gallo, Gloria [UNIFESP]
• Data de Publicação: 2011
• Outros Autores: Ramos, Thiago Cesar Prata [UNIFESP], Tavares, Fernanda, Rocha, Antonio Augusto [UNIFESP], Machi, Emerson, Schenkman, Sergio [UNIFESP], Bahia, Diana [UNIFESP], Pesquero, João Bosco [UNIFESP], Wuertele, Martin [UNIFESP]
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UNIFESP
• Texto Completo: http://repositorio.unifesp.br/handle/11600/33701; http://dx.doi.org/10.1016/j.bbrc.2011.04.038
• topic: Protein tyrosine phosphatase; Trypanosoma cruzi; Chagas' disease; Recombinant expression

Protein tyrosine phosphatases (PTPs) form a large family of enzymes involved in the regulation of numerous cellular functions in eukaryotes. Several protein tyrosine phosphatases have been recently identified in trypanosomatides. Here we report the purification and biochemical characterization of TcPTP1, a protein tyrosine phosphatase from Trypanosoma cruzi, the causing agent of Chagas' disease. the enzyme was cloned and expressed recombinantly in Escherichia coli and purified by Ni-affinity chromatography. Biochemical characterization of recombinant TcPTP1 with the PTP pseudo-substrate pNPP allowed the estimation of a Michaelis-Menten constant K-m of 4.5 mM and a k(cat) of 2.8 s(-1). We were able to demonstrate inhibition of the enzyme by the PTP1b inhibitor BZ3, which on its turn was able to accelerate the differentiation of epimastigotes into metacyclic forms of T. cruzi induced by nutritional stress. Additionally, this compound was able to inhibit by 50% the infectivity of T. cruzi trypomastigotes in a separate cellular assay. in conclusion our results indicate that TcPTP1 is of importance for cellular differentiation and invasivity of this parasite and thus is a valid target for the rational drug design of potential antibiotics directed against T. cruzi. (C) 2011 Elsevier Inc. All rights reserved.